Skip to main content
logo
COSCIENS Biopharma Inc. (TSX:CSCI)
Canada flag Canada · Delayed Price · Currency is CAD
2.850
+0.020 (0.71%)
Apr 10, 2026, 3:13 PM EST

COSCIENS Biopharma Revenue

In the year 2025, COSCIENS Biopharma had annual revenue of $7.50M USD, down -21.79%. COSCIENS Biopharma had revenue of $1.77M in the quarter ending December 31, 2025, a decrease of -46.84%.

Revenue
$7.50M
Revenue Growth
-21.79%
P/S Ratio
0.88
Revenue / Employee
$267.79K
Employees
28
Market Cap
9.07M CAD

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20257.50M-2.09M-21.79%
Dec 31, 20249.59M2.44M34.22%
Dec 31, 20237.14M-7.43M-50.98%
Dec 31, 202214.57M9.31M177.03%
Dec 31, 20215.26M1.61M44.03%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Innovotech4.53M
Rapid Dose Therapeutics2.78M
Glow Lifetech2.05M
Pharmala Biotech Holdings754.64K
Britannia Life Sciences157.68K
Revenue Rankings

COSCIENS Biopharma News

More News